1. Home
  2. RCAT vs INSP Comparison

RCAT vs INSP Comparison

Compare RCAT & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCAT
  • INSP
  • Stock Information
  • Founded
  • RCAT 2002
  • INSP 2007
  • Country
  • RCAT United States
  • INSP United States
  • Employees
  • RCAT N/A
  • INSP N/A
  • Industry
  • RCAT Wholesale Distributors
  • INSP Medical/Dental Instruments
  • Sector
  • RCAT Industrials
  • INSP Health Care
  • Exchange
  • RCAT Nasdaq
  • INSP Nasdaq
  • Market Cap
  • RCAT N/A
  • INSP 4.4B
  • IPO Year
  • RCAT 2017
  • INSP 2018
  • Fundamental
  • Price
  • RCAT $5.13
  • INSP $150.21
  • Analyst Decision
  • RCAT Strong Buy
  • INSP Buy
  • Analyst Count
  • RCAT 2
  • INSP 10
  • Target Price
  • RCAT $8.50
  • INSP $222.20
  • AVG Volume (30 Days)
  • RCAT 4.8M
  • INSP 463.9K
  • Earning Date
  • RCAT 03-31-2025
  • INSP 05-05-2025
  • Dividend Yield
  • RCAT N/A
  • INSP N/A
  • EPS Growth
  • RCAT N/A
  • INSP N/A
  • EPS
  • RCAT N/A
  • INSP 1.75
  • Revenue
  • RCAT $7,275,456.00
  • INSP $802,804,000.00
  • Revenue This Year
  • RCAT $423.86
  • INSP $20.65
  • Revenue Next Year
  • RCAT $206.40
  • INSP $17.49
  • P/E Ratio
  • RCAT N/A
  • INSP $83.95
  • Revenue Growth
  • RCAT N/A
  • INSP 28.49
  • 52 Week Low
  • RCAT $0.80
  • INSP $123.00
  • 52 Week High
  • RCAT $15.27
  • INSP $257.40
  • Technical
  • Relative Strength Index (RSI)
  • RCAT 40.83
  • INSP 44.54
  • Support Level
  • RCAT $4.97
  • INSP $137.97
  • Resistance Level
  • RCAT $6.42
  • INSP $152.25
  • Average True Range (ATR)
  • RCAT 0.87
  • INSP 10.34
  • MACD
  • RCAT -0.09
  • INSP 0.57
  • Stochastic Oscillator
  • RCAT 5.37
  • INSP 55.92

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: